AAPL   328.64 (+1.96%)
GOOGL   1,435.97 (+1.53%)
AMZN   2,466.53 (+0.24%)
CGC   16.84 (+1.20%)
BABA   219.45 (+0.65%)
MU   54.03 (+5.47%)
GE   8.27 (+6.85%)
TSLA   873.90 (+1.10%)
T   32.88 (+3.40%)
ACB   13.81 (-2.95%)
GILD   77.30 (-0.31%)
DIS   126.68 (+2.42%)
NFLX   414.80 (+0.11%)
BAC   28.48 (+6.35%)
BA   215.35 (+16.85%)
AAPL   328.64 (+1.96%)
GOOGL   1,435.97 (+1.53%)
AMZN   2,466.53 (+0.24%)
CGC   16.84 (+1.20%)
BABA   219.45 (+0.65%)
MU   54.03 (+5.47%)
GE   8.27 (+6.85%)
TSLA   873.90 (+1.10%)
T   32.88 (+3.40%)
ACB   13.81 (-2.95%)
GILD   77.30 (-0.31%)
DIS   126.68 (+2.42%)
NFLX   414.80 (+0.11%)
BAC   28.48 (+6.35%)
BA   215.35 (+16.85%)
AAPL   328.64 (+1.96%)
GOOGL   1,435.97 (+1.53%)
AMZN   2,466.53 (+0.24%)
CGC   16.84 (+1.20%)
BABA   219.45 (+0.65%)
MU   54.03 (+5.47%)
GE   8.27 (+6.85%)
TSLA   873.90 (+1.10%)
T   32.88 (+3.40%)
ACB   13.81 (-2.95%)
GILD   77.30 (-0.31%)
DIS   126.68 (+2.42%)
NFLX   414.80 (+0.11%)
BAC   28.48 (+6.35%)
BA   215.35 (+16.85%)
AAPL   328.64 (+1.96%)
GOOGL   1,435.97 (+1.53%)
AMZN   2,466.53 (+0.24%)
CGC   16.84 (+1.20%)
BABA   219.45 (+0.65%)
MU   54.03 (+5.47%)
GE   8.27 (+6.85%)
TSLA   873.90 (+1.10%)
T   32.88 (+3.40%)
ACB   13.81 (-2.95%)
GILD   77.30 (-0.31%)
DIS   126.68 (+2.42%)
NFLX   414.80 (+0.11%)
BAC   28.48 (+6.35%)
BA   215.35 (+16.85%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HumanigenObsevaChembio DiagnosticsMustang BioNorthwest Biotherapeutics
SymbolOTCMKTS:HGENNASDAQ:OBSVNASDAQ:CEMINASDAQ:MBIOOTCMKTS:NWBO
Price Information
Current Price$2.82$5.01$8.40$4.03$0.35
52 Week RangeN/ABuyBuyBuyN/A
Beat the Market™ Rank
Overall Score0.51.52.01.80.5
Analysis Score0.03.43.43.50.0
Community Score2.52.32.52.42.6
Dividend Score0.00.00.00.00.0
Ownership Score0.01.01.03.00.0
Earnings & Valuation Score0.00.63.10.00.0
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyN/A
Consensus Price TargetN/A$22.25$15.25$9.00N/A
% Upside from Price TargetN/A344.11% upside81.55% upside123.33% upsideN/A
Trade Information
Market Cap$369.10 million$243.34 million$158.29 million$160.24 million$237.90 million
Beta-1.581.042.31.691.59
Average Volume106,506899,5351,149,864524,0703,300,048
Sales & Book Value
Annual RevenueN/AN/A$34.46 millionN/A$2.41 million
Price / SalesN/AN/A4.28N/A99.29
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.13) per share$1.01 per share$1.37 per share$1.25 per share($0.07) per share
Price / BookN/AN/A6.13N/A-4.93
Profitability
Net Income$-10,290,000.00$-108,790,000.00$-13,680,000.00$-46,390,000.00$-20,300,000.00
EPSN/A($2.49)($0.79)($1.29)N/A
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/A7.12N/A
P/E GrowthN/AN/A$0.59N/AN/A
Net MarginsN/AN/A-48.02%N/A-842.16%
Return on Equity (ROE)N/A-167.15%-63.13%-84.09%N/A
Return on Assets (ROA)-1,303.57%-91.89%-29.41%-61.08%-138.90%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.69%1.36%0.28%N/A
Current Ratio0.02%2.87%3.48%5.75%0.08%
Quick Ratio0.02%2.87%2.11%5.75%0.08%
Ownership Information
Institutional Ownership PercentageN/A53.03%39.87%20.87%0.03%
Insider Ownership Percentage7.10%N/A4.90%2.10%21.30%
Miscellaneous
Employees3432953814
Shares Outstanding126.40 million48.57 million17.55 million42.84 million693.57 million
Next Earnings Date8/10/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)8/14/2020 (Estimated)6/5/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.